Verivas is used to lower the risk of cardiovascular death and heart failure (HF) hospitalization in adults with symptomatic chronic heart failure and an ejection fraction below 45%, particularly after a recent HF hospitalization or a need for outpatient IV diuretics.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Vericiguat is a soluble guanylate cyclase (sGC) stimulator, a key enzyme in the nitric oxide (NO) signaling pathway.
By directly stimulating sGC—both independently and alongside NO—Vericiguat raises intracellular cGMP levels, promoting smooth muscle relaxation and vasodilation, ultimately improving cardiovascular performance.
No dose adjustment needed for mild to moderate liver impairment.
Pediatric Use
Safety and effectiveness have not been established for children or adolescents.
Common adverse effects include:
Low blood pressure (hypotension)
Anemia (low red blood cell count)
Other sGC stimulators: Must not be used with Verivas.
PDE-5 inhibitors (e.g., sildenafil) due to the risk of excessive hypotension.
Must be taken with food for optimal absorption (bioavailability ~93%).
Contraindicated—may cause fetal harm.
Confirm absence of pregnancy before treatment.
Women of reproductive potential must use effective contraception during treatment and for 1 month after therapy.
Unknown if Vericiguat passes into breast milk.
Breastfeeding is not recommended during treatment due to potential serious adverse effects on infants.
Store below 30°C, protected from light and moisture.
Keep all medicines out of reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.